Join to view full profile
200 UCLA Medical Plz Ste B265Los Angeles, CA 90095
Phone+1 310-267-5575
Dr. Ebrahimi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sasha Ebrahimi is a Radiation Oncology resident based in Los Angeles, CA. He is currently completing his residency in Radiation Oncology at UCLA David Geffen School of Medicine/UCLA Medical Center after completing a transitional year internship at HCA Healthcare Riverside in 2022-2023. Dr. Ebrahimi graduated from Mayo Clinic College of Medicine in 2022 and holds a PhD in Molecular Biology from the University of Toronto, where he was a Canada Vanier Scholar.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2023 - 2027
HCA Healthcare RiversideInternship, Transitional Year, 2022 - 2023
Mayo Clinic College of MedicineClass of 2022
University of TorontoPhD, Molecular Biology, Canada Vanier Scholar, 2011 - 2017- University of TorontoBS, Human Biology, 2005 - 2009
Certifications & Licensure
CA State Medical License 2023 - 2027
Publications & Presentations
PubMed
- Efficacy and safety of adrenalectomy and stereotactic ablative radiotherapy (SABR) for adrenal metastases: A systematic review and meta-analysis.Nicolas Giraud, Peter S N van Rossum, Sasha Ebrahimi, Miguel A Palacios, Drew Moghanaki
Radiotherapy and Oncology. 2026-08-01 - Endoscopic Spacer-Assisted Stereotactic Body Radiation Therapy for Abdominal Oligometastases: A Novel Technique to Reduce Gastrointestinal Toxicity.Sasha Ebrahimi, Jonathan Pham, Albert J Chang
Advances in Radiation Oncology. 2026-05-01 - 1 citationsDiet, nutrition, and hormone therapy for prostate cancer: a systematic review with implications for future interventions.Isabella Pahulu, Matthew Calumpit, Paul Tominez, Jonathan J Shih, Sasha Ebrahimi
JNCI Cancer Spectrum. 2026-03-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
